Stock ALT ALTIMMUNE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Altimmune, Inc.

Equities

ALT

US02155H2004

Market Closed - Nasdaq
Other stock markets
 04:00:01 2024-05-31 pm EDT 		5-day change 1st Jan Change
7.51 USD +6.98% Intraday chart for Altimmune, Inc. +2.46% -33.24%
May. 23 Transcript : Altimmune, Inc. Presents at UBS Obesity Therapeutics Day, May-23-2024 10:00 AM
May. 09 Transcript : Altimmune, Inc., Q1 2024 Earnings Call, May 09, 2024

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
Altimmune to Present Clinical Data from Pemvidutide at Upcoming EASL International Liver Congress 2024
Shareholders that lost money on Altimmune, Inc.(ALT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT
Altimmune to Present Clinical Data from Pemvidutide at Upcoming EASL International Liver Congress™ 2024
Altimmune to Participate at Two Upcoming Investor Conferences
The Gross Law Firm Notifies Shareholders of Altimmune, Inc.(ALT) of a Class Action Lawsuit and an Upcoming Deadline
ALT LOSS ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
Transcript : Altimmune, Inc. Presents at UBS Obesity Therapeutics Day, May-23-2024 10:00 AM
Altimmune, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 5, 2024 to Discuss Your Rights - ALT
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
ALT INVESTOR NOTICE: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALT
Roundhill Investments Launches GLP-1 & Weight Loss ETF (OZEM)
The Gross Law Firm Notifies Altimmune, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ALT
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
Robbins LLP Urges Altimmune, Inc. (ALT) Stockholders With Large Losses to Contact the Firm for Information About Their Rights
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALT Stock
  4. News Altimmune, Inc.
  5. Other languages